Hip Fracture
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged >=65 years, regardless of gender 2. Diagnosed with unilateral hip fracture due to low-energy trauma by imaging (X-ray/CT), and having completed surgical treatment (internal fixation or arthroplasty) 3. The participant or legal guardian understands and agrees to participate in the clinical trial, and willing to provide voluntary written informed consent
Exclusion criteria
Exclusion criteria: 1. Life expectancy 100 kg); 5. Height outside the adjustable range of the device; 6. Presence of a pathological fracture or multiple fragility fractures; 7. Presence of severe osteoarthritis or trauma in the contralateral lower limb that significantly impairs function; 8. Comorbidities including active malignancy or systemic infection; 9. Comorbidities such as thromboembolic disease in the lower limbs, pneumonia, or pressure injuries (bedsores); 10. Comorbidities affecting rehabilitation capacity, including unstable angina, heart failure, severe sequelae of stroke, severe chronic obstructive pulmonary disease (COPD), or severe hepatic/renal dysfunction; 11. Poor compliance, cognitive impairment preventing cooperation, or diagnosed psychiatric disorders such as depression or anxiety; 12. Participation in any other clinical trial within 3 months prior to screening.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Harris Hip Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Timed Up and Go Test;6-Minute Walk Test;Berg Balance Scale;Range of Motion Measurement;Psychological Assessment;Proteomic Analysis;Visual Analogue Scale; | — |
Countries
China
Contacts
Beijing Jishuitan Hospital, Capital Medical University